{"transactions":[{"id":714298,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-06T20:01:13.000Z","date":"2026-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":14650,"price":4.46,"value":65339.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units previously granted."}],"balance_after":261107,"source":{"system":"sec-edgar","filing":"0001628280-26-047217","document":"wk-form4_1783368070.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000162828026047217/wk-form4_1783368070.xml","form_type":"4"}},{"id":774241,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-18T20:42:24.000Z","date":"2026-05-15","kind":"purchase","planned":false,"acquired":true,"shares":7100,"price":2.43,"value":17253.0,"ownership":{"direct":true},"balance_after":275757,"source":{"system":"sec-edgar","filing":"0001628280-26-035992","document":"wk-form4_1779136942.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000162828026035992/wk-form4_1779136942.xml","form_type":"4"}},{"id":887421,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-23T21:08:30.000Z","date":"2026-02-23","kind":"purchase","planned":false,"acquired":true,"shares":3657,"price":4.1,"value":14993.7,"ownership":{"direct":true},"balance_after":268657,"source":{"system":"sec-edgar","filing":"0001628280-26-010606","document":"wk-form4_1771880906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000162828026010606/wk-form4_1771880906.xml","form_type":"4"}},{"id":988299,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-11-25T20:40:45.000Z","date":"2025-11-24","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of November 24, 2025 (the \"VCD\"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to continued employment through the respective vesting date."}],"balance_after":668899,"derivative":{"exercise_price":5.55,"expiration_date":"2035-11-23","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001970009-25-000004","document":"wk-form4_1764103242.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000197000925000004/wk-form4_1764103242.xml","form_type":"4"}},{"id":988298,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-25T20:40:45.000Z","date":"2025-11-24","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on November 24, 2025, subject to continued employment through the respective vesting date."}],"balance_after":265000,"source":{"system":"sec-edgar","filing":"0001970009-25-000004","document":"wk-form4_1764103242.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000197000925000004/wk-form4_1764103242.xml","form_type":"4"}},{"id":1052550,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-08-29T20:18:12.000Z","date":"2025-08-28","kind":"grant","planned":false,"acquired":true,"shares":248899,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the granting of stock options upon achieving or exceeding $75 million of revenue over any twelve (12) consecutive calendar month period ending on or before December 31, 2027. The options vest immediately upon achieving the performance requirement, subject to the Reporting Person's continued service with the Issuer on each respective vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The stock options expire on December 31, 2027 if the revenue threshold is not met."}],"balance_after":538899,"derivative":{"exercise_price":5.11,"underlying":"Common Stock","underlying_shares":248899},"source":{"system":"sec-edgar","filing":"0001826667-25-000131","document":"wk-form4_1756498688.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000182666725000131/wk-form4_1756498688.xml","form_type":"4"}},{"id":1064947,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-08-15T21:29:18.000Z","date":"2025-08-14","kind":"grant","planned":false,"acquired":true,"shares":290000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of July 1, 2026 (the \"VCD\"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date."}],"balance_after":290000,"derivative":{"exercise_price":3.88,"expiration_date":"2035-08-13","underlying":"Common Stock","underlying_shares":290000},"source":{"system":"sec-edgar","filing":"0001826667-25-000121","document":"wk-form4_1755293353.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000182666725000121/wk-form4_1755293353.xml","form_type":"4"}},{"id":1064946,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-15T21:29:18.000Z","date":"2025-08-14","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on July 1, 2026, subject to the Reporting Person's continued service with the Issuer on each respective vesting date."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001826667-25-000121","document":"wk-form4_1755293353.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1826667/000182666725000121/wk-form4_1755293353.xml","form_type":"4"}},{"id":1185486,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Restricted Stock Units","published_at":"2025-04-02T18:12:07.000Z","date":"2025-04-01","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On April 1, 2023, the reporting person was granted a total of 50,000 RSUs, of which 40% vest on April 1, 2025 and the remaining 60% vest on April 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On April 1, 2023, the reporting person was granted a total of 50,000 RSUs, of which 40% vest on April 1, 2025 and the remaining 60% vest on April 1, 2026."}],"balance_after":30000,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-25-031298","document":"tm2511279-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465925031298/tm2511279-1_4seq1.xml","form_type":"4"}},{"id":1185485,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-04-02T18:12:07.000Z","date":"2025-04-01","kind":"sale","planned":false,"acquired":false,"shares":6816,"price":0.71,"value":4839.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the reporting person."}],"balance_after":64568,"source":{"system":"sec-edgar","filing":"0001104659-25-031298","document":"tm2511279-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465925031298/tm2511279-1_4seq1.xml","form_type":"4"}},{"id":1185484,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-04-02T18:12:07.000Z","date":"2025-04-01","kind":"exercise","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the issuer's common stock upon vesting."}],"balance_after":71384,"source":{"system":"sec-edgar","filing":"0001104659-25-031298","document":"tm2511279-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465925031298/tm2511279-1_4seq1.xml","form_type":"4"}},{"id":1242010,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Restricted Stock Units","published_at":"2025-02-27T19:24:56.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 26, 2022, the reporting person was granted a total of 2,500 RSUs, of which 40% vest on February 26, 2024 and the remaining 60% vest on February 26, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 26, 2022, the reporting person was granted a total of 2,500 RSUs, of which 40% vest on February 26, 2024 and the remaining 60% vest on February 26, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001104659-25-018521","document":"tm257797-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465925018521/tm257797-1_4seq1.xml","form_type":"4"}},{"id":1242009,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-27T19:24:56.000Z","date":"2025-02-26","kind":"sale","planned":false,"acquired":false,"shares":535,"price":1.09,"value":583.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the reporting person."}],"balance_after":51384,"source":{"system":"sec-edgar","filing":"0001104659-25-018521","document":"tm257797-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465925018521/tm257797-1_4seq1.xml","form_type":"4"}},{"id":1242008,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-27T19:24:56.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the issuer's common stock upon vesting."}],"balance_after":51919,"source":{"system":"sec-edgar","filing":"0001104659-25-018521","document":"tm257797-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465925018521/tm257797-1_4seq1.xml","form_type":"4"}},{"id":1498609,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Restricted Stock Units","published_at":"2024-05-30T16:15:29.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 29, 2024, the reporting person was granted a total of 120,000 RSUs, of which 40% vest on May 29, 2026 and the remaining 60% vest on May 29, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 29, 2024, the reporting person was granted a total of 120,000 RSUs, of which 40% vest on May 29, 2026 and the remaining 60% vest on May 29, 2027."}],"balance_after":120000,"derivative":{"underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001104659-24-066658","document":"tm2415918-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465924066658/tm2415918-1_4seq1.xml","form_type":"4"}},{"id":1544132,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Restricted Stock Units","published_at":"2024-04-10T17:27:13.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":false,"shares":37468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On March 5, 2024, the reporting person was granted a total of 37,468 restricted stock units (\"RSUs\"), which vest on April 9, 2024. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 5, 2024, the reporting person was granted a total of 37,468 restricted stock units (\"RSUs\"), which vest on April 9, 2024. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On March 5, 2024, the reporting person was granted a total of 37,468 restricted stock units (\"RSUs\"), which vest on April 9, 2024. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":37468},"source":{"system":"sec-edgar","filing":"0001104659-24-045899","document":"tm2411517-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465924045899/tm2411517-2_4seq1.xml","form_type":"4"}},{"id":1544131,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-10T17:27:13.000Z","date":"2024-04-09","kind":"sale","planned":false,"acquired":false,"shares":13296,"price":0.87,"value":11567.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the reporting person."}],"balance_after":50419,"source":{"system":"sec-edgar","filing":"0001104659-24-045899","document":"tm2411517-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465924045899/tm2411517-2_4seq1.xml","form_type":"4"}},{"id":1544130,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-10T17:27:13.000Z","date":"2024-04-09","kind":"exercise","planned":false,"acquired":true,"shares":37468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 5, 2024, the reporting person was granted a total of 37,468 restricted stock units (\"RSUs\"), which vest on April 9, 2024. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 5, 2024, the reporting person was granted a total of 37,468 restricted stock units (\"RSUs\"), which vest on April 9, 2024. Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting."}],"balance_after":63715,"source":{"system":"sec-edgar","filing":"0001104659-24-045899","document":"tm2411517-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465924045899/tm2411517-2_4seq1.xml","form_type":"4"}},{"id":1593119,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Restricted Stock Units","published_at":"2024-03-06T19:32:29.000Z","date":"2024-03-05","kind":"grant","planned":false,"acquired":true,"shares":37468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 5, 2024, the reporting person was granted a total of 37,468 RSUs, which vest on April 9, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 5, 2024, the reporting person was granted a total of 37,468 RSUs, which vest on April 9, 2024."}],"balance_after":37468,"derivative":{"underlying":"Common Stock","underlying_shares":37468},"source":{"system":"sec-edgar","filing":"0001104659-24-031600","document":"tm248096-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465924031600/tm248096-3_4seq1.xml","form_type":"4"}},{"id":1617850,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Restricted Stock Units","published_at":"2024-02-27T18:59:40.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On February 26, 2022, the reporting person was granted a total of 2,500 restricted stock units (\"RSUs\"), of which 40% vest on February 26, 2024 and the remaining 60% vest on February 26, 2025. Each RSU represents a contingent right to receive one share of the issuer's common stock for each RSU upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 26, 2022, the reporting person was granted a total of 2,500 restricted stock units (\"RSUs\"), of which 40% vest on February 26, 2024 and the remaining 60% vest on February 26, 2025. Each RSU represents a contingent right to receive one share of the issuer's common stock for each RSU upon vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 26, 2022, the reporting person was granted a total of 2,500 restricted stock units (\"RSUs\"), of which 40% vest on February 26, 2024 and the remaining 60% vest on February 26, 2025. Each RSU represents a contingent right to receive one share of the issuer's common stock for each RSU upon vesting."}],"balance_after":1500,"derivative":{"underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001104659-24-028325","document":"tm247362-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465924028325/tm247362-1_4seq1.xml","form_type":"4"}},{"id":1617849,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-27T18:59:40.000Z","date":"2024-02-26","kind":"sale","planned":false,"acquired":false,"shares":350,"price":0.96,"value":336.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the reporting person."}],"balance_after":26247,"source":{"system":"sec-edgar","filing":"0001104659-24-028325","document":"tm247362-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465924028325/tm247362-1_4seq1.xml","form_type":"4"}},{"id":1617848,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-27T18:59:40.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 26, 2022, the reporting person was granted a total of 2,500 restricted stock units (\"RSUs\"), of which 40% vest on February 26, 2024 and the remaining 60% vest on February 26, 2025. Each RSU represents a contingent right to receive one share of the issuer's common stock for each RSU upon vesting."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 26, 2022, the reporting person was granted a total of 2,500 restricted stock units (\"RSUs\"), of which 40% vest on February 26, 2024 and the remaining 60% vest on February 26, 2025. Each RSU represents a contingent right to receive one share of the issuer's common stock for each RSU upon vesting."}],"balance_after":26597,"source":{"system":"sec-edgar","filing":"0001104659-24-028325","document":"tm247362-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465924028325/tm247362-1_4seq1.xml","form_type":"4"}},{"id":1671550,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock Warrants (right to buy)","published_at":"2024-01-25T16:10:28.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":16666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 16,666 units of the issuer (the \"Units\") purchased by the reporting person for $1.50 per Unit from the issuer in an offering exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended. Each Unit consists of one share of the issuer's common stock and one warrant to purchase one share of the issuer's common stock."}],"balance_after":16666,"derivative":{"exercise_price":1.65,"exercise_date":"2024-01-23","expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":16666},"source":{"system":"sec-edgar","filing":"0001104659-24-006671","document":"tm244005-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465924006671/tm244005-1_4seq1.xml","form_type":"4"}},{"id":1671549,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-25T16:10:28.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":16666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 16,666 units of the issuer (the \"Units\") purchased by the reporting person for $1.50 per Unit from the issuer in an offering exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended. Each Unit consists of one share of the issuer's common stock and one warrant to purchase one share of the issuer's common stock."}],"balance_after":25597,"source":{"system":"sec-edgar","filing":"0001104659-24-006671","document":"tm244005-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465924006671/tm244005-1_4seq1.xml","form_type":"4"}},{"id":1711781,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Restricted Stock Units","published_at":"2023-12-14T17:14:02.000Z","date":"2023-12-13","kind":"exercise","planned":false,"acquired":false,"shares":331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reporting person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The reporting person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":331},"source":{"system":"sec-edgar","filing":"0001104659-23-126067","document":"tm2332887-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465923126067/tm2332887-1_4seq1.xml","form_type":"4"}},{"id":1711780,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-14T17:14:02.000Z","date":"2023-12-13","kind":"sale","planned":false,"acquired":false,"shares":97,"price":4.39,"value":425.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the reporting person."}],"balance_after":8931,"source":{"system":"sec-edgar","filing":"0001104659-23-126067","document":"tm2332887-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465923126067/tm2332887-1_4seq1.xml","form_type":"4"}},{"id":1711779,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-14T17:14:02.000Z","date":"2023-12-13","kind":"exercise","planned":false,"acquired":true,"shares":331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."}],"balance_after":9028,"source":{"system":"sec-edgar","filing":"0001104659-23-126067","document":"tm2332887-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465923126067/tm2332887-1_4seq1.xml","form_type":"4"}},{"id":1743094,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Restricted Stock Units","published_at":"2023-11-14T17:02:17.000Z","date":"2023-11-13","kind":"exercise","planned":false,"acquired":false,"shares":331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reporting person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The reporting person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."}],"balance_after":331,"derivative":{"underlying":"Common Stock","underlying_shares":331},"source":{"system":"sec-edgar","filing":"0001104659-23-118221","document":"tm2330666-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465923118221/tm2330666-1_4seq1.xml","form_type":"4"}},{"id":1743093,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-14T17:02:17.000Z","date":"2023-11-13","kind":"sale","planned":false,"acquired":false,"shares":97,"price":5.57,"value":540.29,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the reporting person."}],"balance_after":8697,"source":{"system":"sec-edgar","filing":"0001104659-23-118221","document":"tm2330666-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465923118221/tm2330666-1_4seq1.xml","form_type":"4"}},{"id":1743092,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-14T17:02:17.000Z","date":"2023-11-13","kind":"exercise","planned":false,"acquired":true,"shares":331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."}],"balance_after":8794,"source":{"system":"sec-edgar","filing":"0001104659-23-118221","document":"tm2330666-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465923118221/tm2330666-1_4seq1.xml","form_type":"4"}},{"id":1760340,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Restricted Stock Units","published_at":"2023-10-16T17:17:42.000Z","date":"2023-10-13","kind":"exercise","planned":false,"acquired":false,"shares":331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reporting person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The reporting person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."}],"balance_after":662,"derivative":{"underlying":"Common Stock","underlying_shares":331},"source":{"system":"sec-edgar","filing":"0001628280-23-034442","document":"wk-form4_1697491053.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023034442/wk-form4_1697491053.xml","form_type":"4"}},{"id":1760339,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-16T17:17:42.000Z","date":"2023-10-13","kind":"sale","planned":false,"acquired":false,"shares":96,"price":5.83,"value":559.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the reporting person."}],"balance_after":8463,"source":{"system":"sec-edgar","filing":"0001628280-23-034442","document":"wk-form4_1697491053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023034442/wk-form4_1697491053.xml","form_type":"4"}},{"id":1760338,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-16T17:17:42.000Z","date":"2023-10-13","kind":"exercise","planned":false,"acquired":true,"shares":331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."}],"balance_after":8559,"source":{"system":"sec-edgar","filing":"0001628280-23-034442","document":"wk-form4_1697491053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023034442/wk-form4_1697491053.xml","form_type":"4"}},{"id":1781605,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Restricted Stock Units","published_at":"2023-09-14T16:11:17.000Z","date":"2023-09-13","kind":"exercise","planned":false,"acquired":false,"shares":331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reporting person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The reporting person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."}],"balance_after":993,"derivative":{"underlying":"Common Stock","underlying_shares":331},"source":{"system":"sec-edgar","filing":"0001104659-23-100789","document":"tm2326124-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465923100789/tm2326124-1_4seq1.xml","form_type":"4"}},{"id":1781604,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-14T16:11:17.000Z","date":"2023-09-13","kind":"sale","planned":false,"acquired":false,"shares":96,"price":6.53,"value":626.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the reporting person."}],"balance_after":8228,"source":{"system":"sec-edgar","filing":"0001104659-23-100789","document":"tm2326124-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465923100789/tm2326124-1_4seq1.xml","form_type":"4"}},{"id":1781603,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-14T16:11:17.000Z","date":"2023-09-13","kind":"exercise","planned":false,"acquired":true,"shares":331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of the issuer's common stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 RSUs, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."}],"balance_after":8324,"source":{"system":"sec-edgar","filing":"0001104659-23-100789","document":"tm2326124-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465923100789/tm2326124-1_4seq1.xml","form_type":"4"}},{"id":1808001,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Restricted Stock Units","published_at":"2023-08-15T19:22:00.000Z","date":"2023-08-13","kind":"exercise","planned":false,"acquired":false,"shares":331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."}],"balance_after":1324,"derivative":{"underlying":"Common Stock","underlying_shares":331},"source":{"system":"sec-edgar","filing":"0001628280-23-029596","document":"wk-form4_1692141711.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023029596/wk-form4_1692141711.xml","form_type":"4"}},{"id":1808000,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-15T19:22:00.000Z","date":"2023-08-14","kind":"sale","planned":false,"acquired":false,"shares":95,"price":6.8,"value":646.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":7993,"source":{"system":"sec-edgar","filing":"0001628280-23-029596","document":"wk-form4_1692141711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023029596/wk-form4_1692141711.xml","form_type":"4"}},{"id":1807999,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-15T19:22:00.000Z","date":"2023-08-13","kind":"exercise","planned":false,"acquired":true,"shares":331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."}],"balance_after":8088,"source":{"system":"sec-edgar","filing":"0001628280-23-029596","document":"wk-form4_1692141711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023029596/wk-form4_1692141711.xml","form_type":"4"}},{"id":1829234,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Restricted Stock Units","published_at":"2023-07-17T17:20:21.000Z","date":"2023-07-13","kind":"exercise","planned":false,"acquired":false,"shares":330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."}],"balance_after":1655,"derivative":{"underlying":"Common Stock","underlying_shares":330},"source":{"system":"sec-edgar","filing":"0001628280-23-025009","document":"wk-form4_1689628810.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023025009/wk-form4_1689628810.xml","form_type":"4"}},{"id":1829233,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-07-17T17:20:21.000Z","date":"2023-07-13","kind":"sale","planned":false,"acquired":false,"shares":92,"price":6.9,"value":634.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding\nobligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":7757,"source":{"system":"sec-edgar","filing":"0001628280-23-025009","document":"wk-form4_1689628810.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023025009/wk-form4_1689628810.xml","form_type":"4"}},{"id":1829232,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-07-17T17:20:21.000Z","date":"2023-07-13","kind":"exercise","planned":false,"acquired":true,"shares":330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 3,970 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."}],"balance_after":7849,"source":{"system":"sec-edgar","filing":"0001628280-23-025009","document":"wk-form4_1689628810.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023025009/wk-form4_1689628810.xml","form_type":"4"}},{"id":1850832,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Restricted Stock Units","published_at":"2023-06-20T17:41:04.000Z","date":"2023-06-18","kind":"grant","planned":false,"acquired":true,"shares":611842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received 611,842 restricted stock units on June 18, 2023, of which 40% vests on June 18, 2025 and the remaining 60% will vest on June 18, 2026. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not Applicable."}],"balance_after":611842,"derivative":{"underlying":"Common Stock","underlying_shares":611842},"source":{"system":"sec-edgar","filing":"0001628280-23-022764","document":"wk-form4_1687297248.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023022764/wk-form4_1687297248.xml","form_type":"4"}},{"id":1855279,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Restricted Stock Units","published_at":"2023-06-15T13:19:24.000Z","date":"2023-06-13","kind":"exercise","planned":false,"acquired":false,"shares":3309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 39,707 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 39,707 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 39,707 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."}],"balance_after":19853,"derivative":{"underlying":"Common Stock","underlying_shares":3309},"source":{"system":"sec-edgar","filing":"0001628280-23-022178","document":"wk-form4_1686849552.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023022178/wk-form4_1686849552.xml","form_type":"4"}},{"id":1855278,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-15T13:19:24.000Z","date":"2023-06-13","kind":"sale","planned":false,"acquired":false,"shares":1287,"price":0.9,"value":1158.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":75192,"source":{"system":"sec-edgar","filing":"0001628280-23-022178","document":"wk-form4_1686849552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023022178/wk-form4_1686849552.xml","form_type":"4"}},{"id":1855277,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-15T13:19:24.000Z","date":"2023-06-13","kind":"exercise","planned":false,"acquired":true,"shares":3309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 39,707 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 39,707 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."}],"balance_after":76479,"source":{"system":"sec-edgar","filing":"0001628280-23-022178","document":"wk-form4_1686849552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023022178/wk-form4_1686849552.xml","form_type":"4"}},{"id":1892699,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Restricted Stock Units","published_at":"2023-05-16T17:38:18.000Z","date":"2023-05-15","kind":"exercise","planned":false,"acquired":false,"shares":3309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 39,707 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 39,707 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 39,707 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."}],"balance_after":23162,"derivative":{"underlying":"Common Stock","underlying_shares":3309},"source":{"system":"sec-edgar","filing":"0001628280-23-018496","document":"wk-form4_1684273088.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023018496/wk-form4_1684273088.xml","form_type":"4"}},{"id":1892698,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-16T17:38:18.000Z","date":"2023-05-15","kind":"sale","planned":false,"acquired":false,"shares":1222,"price":0.69,"value":843.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":73170,"source":{"system":"sec-edgar","filing":"0001628280-23-018496","document":"wk-form4_1684273088.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023018496/wk-form4_1684273088.xml","form_type":"4"}},{"id":1892697,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-16T17:38:18.000Z","date":"2023-05-15","kind":"exercise","planned":false,"acquired":true,"shares":3309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 39,707 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 39,707 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."}],"balance_after":74392,"source":{"system":"sec-edgar","filing":"0001628280-23-018496","document":"wk-form4_1684273088.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023018496/wk-form4_1684273088.xml","form_type":"4"}},{"id":1919265,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Restricted Stock Units","published_at":"2023-04-17T21:54:45.000Z","date":"2023-04-13","kind":"exercise","planned":false,"acquired":false,"shares":3309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 39,707 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 39,707 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 39,707 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."}],"balance_after":26471,"derivative":{"underlying":"Common Stock","underlying_shares":3309},"source":{"system":"sec-edgar","filing":"0001628280-23-011840","document":"wf-form4_168178287326590.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023011840/wf-form4_168178287326590.xml","form_type":"4"}},{"id":1919264,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-04-17T21:54:45.000Z","date":"2023-04-13","kind":"sale","planned":false,"acquired":false,"shares":1147,"price":0.65,"value":745.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":71083,"source":{"system":"sec-edgar","filing":"0001628280-23-011840","document":"wf-form4_168178287326590.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023011840/wf-form4_168178287326590.xml","form_type":"4"}},{"id":1919263,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-04-17T21:54:45.000Z","date":"2023-04-13","kind":"exercise","planned":false,"acquired":true,"shares":3309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 39,707 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 39,707 restricted stock units, which vests in equal amounts every month for 12 months, which started vesting on January 13, 2023."}],"balance_after":72230,"source":{"system":"sec-edgar","filing":"0001628280-23-011840","document":"wf-form4_168178287326590.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023011840/wf-form4_168178287326590.xml","form_type":"4"}},{"id":1931101,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":31930,"kind":"person","name":"Patience David","position":1,"cik":"0001970009","reported_name":"Patience David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Restricted Stock Units","published_at":"2023-04-04T21:31:55.000Z","date":"2023-04-01","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received 500,000 restricted stock units on April 1, 2023, of which 40% vests on April 1, 2025 and the remaining 60% will vest on April 1, 2026. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not Applicable."}],"balance_after":500000,"derivative":{"underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001628280-23-010787","document":"wf-form4_168065830497403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023010787/wf-form4_168065830497403.xml","form_type":"4"}}]}